Publikationen in Zusammenarbeit mit Forschern von National Cancer Center (2)

2020

  1. Health-Related Quality of Life in MONARCH 3: Abemaciclib plus an Aromatase Inhibitor as Initial Therapy in HR+, HER2− Advanced Breast Cancer

    Oncologist, Vol. 25, Núm. 9, pp. e1346-e1354

2013

  1. A phase two randomised trial of neratinib monotherapy versus lapatinib plus capecitabine combination therapy in patients with HER2+ advanced breast cancer

    European Journal of Cancer, Vol. 49, Núm. 18, pp. 3763-3772